Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP766922.RA522sFYESthjA-y_zDZG4EC9rBpCQoAdGlNmQX_xCNXM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP766922.RA522sFYESthjA-y_zDZG4EC9rBpCQoAdGlNmQX_xCNXM130_assertion type Assertion NP766922.RA522sFYESthjA-y_zDZG4EC9rBpCQoAdGlNmQX_xCNXM130_head.
- NP766922.RA522sFYESthjA-y_zDZG4EC9rBpCQoAdGlNmQX_xCNXM130_assertion description "[Cockayne syndrome (CS) cells and xeroderma pigmentosum (XP) cells (XPD, XPA, XPG, and XPF) were defective in Pol II degradation, whereas XPC cells whose defect is limited to global genome NER in nontranscribing regions were proficient for Pol II degradation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766922.RA522sFYESthjA-y_zDZG4EC9rBpCQoAdGlNmQX_xCNXM130_provenance.
- NP766922.RA522sFYESthjA-y_zDZG4EC9rBpCQoAdGlNmQX_xCNXM130_assertion evidence source_evidence_literature NP766922.RA522sFYESthjA-y_zDZG4EC9rBpCQoAdGlNmQX_xCNXM130_provenance.
- NP766922.RA522sFYESthjA-y_zDZG4EC9rBpCQoAdGlNmQX_xCNXM130_assertion SIO_000772 18927284 NP766922.RA522sFYESthjA-y_zDZG4EC9rBpCQoAdGlNmQX_xCNXM130_provenance.
- NP766922.RA522sFYESthjA-y_zDZG4EC9rBpCQoAdGlNmQX_xCNXM130_assertion wasDerivedFrom befree-20150227 NP766922.RA522sFYESthjA-y_zDZG4EC9rBpCQoAdGlNmQX_xCNXM130_provenance.
- NP766922.RA522sFYESthjA-y_zDZG4EC9rBpCQoAdGlNmQX_xCNXM130_assertion wasGeneratedBy ECO_0000203 NP766922.RA522sFYESthjA-y_zDZG4EC9rBpCQoAdGlNmQX_xCNXM130_provenance.